Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

62.69
+3.085.16%
Volume:165.97K
Turnover:10.32M
Market Cap:2.39B
PE:-10.43
High:63.18
Open:60.85
Low:59.97
Close:59.61
52wk High:99.50
52wk Low:30.82
Shares:38.16M
Float Shares:32.89M
Volume Ratio:0.36
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0116
EPS(LYR):-6.0116
ROE:-35.86%
ROA:-22.55%
PB:3.23
PE(LYR):-10.43

Loading ...

XPeng CEO Plays The Anti-Tesla Card: While Optimus Is Closed, IRON Goes Open Source

Benzinga_recent_news
·
Nov 18, 2025

Tesla Rival Xpeng To Release 3 Robotaxi Models, Says Technology Does Not Depend On LiDAR — Optimus Rival IRON Could Be A 'Tour Guide'

Benzinga_recent_news
·
Nov 18, 2025

Why Disc Medicine (IRON) Is Up 7.3% After FDA Priority Review and $250M Capital Raise

Simply Wall St.
·
Nov 16, 2025

H.C. Wainwright Remains a Buy on Disc Medicine (IRON)

TIPRANKS
·
Nov 15, 2025

Disc Medicine COO Jonathan Yen-Wen Yu Reports Disposal of Common Shares

Reuters
·
Nov 14, 2025

Disc Medicine Is Maintained at Buy by Truist Securities

Dow Jones
·
Nov 11, 2025

Disc Medicine price target raised to $114 from $86 at Truist

TIPRANKS
·
Nov 10, 2025

Truist Financial Sticks to Their Buy Rating for Disc Medicine (IRON)

TIPRANKS
·
Nov 10, 2025

Disc Medicine (IRON): A Fresh Look at Valuation Following Key FDA Milestone and Pipeline Advances

Simply Wall St.
·
Nov 08, 2025

Disc Medicine: Strong Financial Position and Promising Product Pipeline with Bitopertin’s Billion-Dollar Potential

TIPRANKS
·
Nov 07, 2025

Disc Medicine’s Promising Pipeline and Regulatory Advancements Justify Buy Rating

TIPRANKS
·
Nov 07, 2025

Earnings Flash (IRON) Disc Medicine Posts Q3 Net Loss $1.77 a Share, vs. FactSet Est of $1.44 Loss

MT Newswires Live
·
Nov 06, 2025

Biopharma firm Disc Medicine's Q3 net loss widens

Reuters
·
Nov 06, 2025

Disc Medicine Q3 EPS $(1.77) Misses $(1.51) Estimate

Benzinga
·
Nov 06, 2025

Disc Medicine reports Q3 EPS ($1.77), consensus ($1.47)

TIPRANKS
·
Nov 06, 2025

Disc Medicine reports Q3 2025 results with cash position of $616 million

Reuters
·
Nov 06, 2025

Disc Medicine Q3 Net Income USD -62.321 Million VS. Ibes Estimate USD -52.1 Million

THOMSON REUTERS
·
Nov 06, 2025

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025

Dow Jones
·
Nov 06, 2025

Disc Medicine Unveils Initial RALLY-MF Phase 2 Data for Anemia in Myelofibrosis at ASH 2025

Reuters
·
Nov 03, 2025

Disc Medicine Announces Presentation of Initial Data From Rally-Mf Phase 2 Trial in Patients With Myelofibrosis (Mf) and Anemia at the 67TH American Society of Hematology (Ash) Annual Meeting

THOMSON REUTERS
·
Nov 03, 2025